2020-12-22,What You Need To Know About ChromaDex Corporation's (NASDAQ:CDXC) Investor Composition
2020-12-14,ChromaDex (CDXC) in Focus: Stock Moves 5.6% Higher
2020-12-02,Is ChromaDex (CDXC) A Good Stock To Buy Now?
2020-12-02,ChromaDex to Present at Benzingas Inaugural Small Cap Conference in December 2020
2020-11-17,ChromaDex Announces New Clinical Trial to Investigate Niagen® and Milk Production Among Mothers in the Neonatal Intensive Care Unit (NICU)
2020-11-09,"ChromaDex and Watsons Launch New TRU NIAGEN® EX Stick Packs in Hong Kong, Expanding Product Line and Advancing Global Retail Partnership"
2020-11-07,Have Insiders Been Buying ChromaDex Corporation (NASDAQ:CDXC) Shares?
2020-11-07,Earnings Update: Here's Why Analysts Just Lifted Their ChromaDex Corporation (NASDAQ:CDXC) Price Target To US$8.00
2020-11-04,ChromaDex Corporation (CDXC) Q3 2020 Earnings Call Transcript
2020-11-04,"ChromaDex (CDXC) Reports Q3 Loss, Misses Revenue Estimates"
2020-11-04,ChromaDex Corporation Reports Third Quarter 2020 Financial Results
2020-11-04,Chromadex Corp. to Host Earnings Call
2020-11-03,Preview: ChromaDex's Earnings
2020-10-28,"ChromaDex to Report Third Quarter 2020 Financial Results on Wednesday, November 4, 2020"
2020-10-27,Oppenheimer: These 3 Stocks Are Poised to Surge by at Least 60%
2020-10-19,"New Study from NIH Finds Nicotinamide Riboside Helps Improve Telomere Dysfunction in Human Cells, Mice"
2020-10-14,Celltrient Cellular Energy Products Featuring Tru Niagen® Launch in US
2020-10-08,New Preclinical Study Finds Nicotinamide Riboside May Improve Immune Cell Function
2020-10-07,ChromaDex Pops 28% On Anti-Ageing Supplement Covid-19 Study
2020-10-06,ChromaDex Announces Study Results Showing Nutritional Protocol Including Nicotinamide Riboside Plus Standard of Care Reduces Recovery Time in COVID-19 Patients by Nearly 30%
2020-09-09,New Preclinical Study Finds Niagen® Prevents Light-Induced Retinal Damage in Mice
2020-09-01,LD Micro: 360 Companies--Set to Present this Week.
2020-08-26,ChromaDex to Present at the LD 500 Virtual Investor Conference
2020-08-18,New Pilot Study Indicates Niagen® May Reduce Inflammatory Cytokines in Stage D Heart Failure Patients
2020-08-06,"ChromaDex (CDXC) Reports Q2 Loss, Tops Revenue Estimates"
2020-08-06,ChromaDex Corporation Reports Second Quarter 2020 Financial Results
2020-08-05,LD Micro - Announces Preliminary List of Presenters for the LD-500
2020-07-30,Will ChromaDex (CDXC) Report Negative Earnings Next Week? What You Should Know
2020-07-28,"ChromaDex to Report Second Quarter 2020 Financial Results on Thursday, August 6, 2020"
2020-07-16,New Preclinical Study Finds Niagen® Corrects Social Deficits in Mouse Model of Autism
2020-07-14,ChromaDex External Research Program (CERP) Achieves 200th Material Transfer Agreement for Niagen® (Nicotinamide Riboside) Research
2020-07-09,ChromaDex Announces New Study Results Highlighting Promising Anti-Viral Effects of Niagen® in Coronavirus Cell Model
2020-07-07,ChromaDex and the NIH-NIAID Rocky Mountain Laboratories Announce Study to Assess the Therapeutic Potential of Niagen® in COVID-19 Animal Models
2020-06-30,New Preclinical Findings Suggest Boosting NAD+ with Niagen® Holds Potential for Slowing Aging Process and Reducing Metabolic Damage
2020-06-17,ChromaDex Research & Development Facility Earns ISO/IEC 17025:2017 Accreditation
2020-06-16,ChromaDex to Present at June 2020 Lytham Partners Virtual Investor Growth Conference
2020-06-16,ChromaDex Commits to COVID-19 Research Following Promising Initial Preclinical Findings Showing Viral Infections Deplete NAD and SARS-CoV-2-Infected Cells Activate NAD Defense Pathway That Utilizes Nicotinamide Riboside (NR)
2020-06-15,Edited Transcript of CDXC.OQ earnings conference call or presentation 11-May-20 8:30pm GMT
2020-06-03,First-of-Its-Kind Human Tissue Study Finds Link Between NAD Decline and Alcohol-Related Liver Disease (ArLD)
2020-06-01,ChromaDex to Host Symposium on NAD+ in Human Health and Disease at NUTRITION 2020 LIVE ONLINE Annual Meeting
2020-05-27,Here is What Hedge Funds Think About ChromaDex Corporation (CDXC)
2020-05-27,ChromaDex to Participate in Panel on Master Files for Dietary Supplements Hosted by the American Conference Institute (ACI) and Council for Responsible Nutrition (CRN)
2020-05-21,ChromaDex Chief Scientific Advisor Dr. Charles Brenner Receives 2020 National Scientific Achievement Award from the American Society for Nutrition
2020-05-12,ChromaDex Corporation (CDXC) Q1 2020 Earnings Call Transcript
2020-05-11,"ChromaDex (CDXC) Reports Q1 Loss, Tops Revenue Estimates"
2020-05-11,ChromaDex Corporation Reports First Quarter 2020 Financial Results
2020-05-06,"Ninth Published Human Trial on Niagen® Nicotinamide Riboside (NR) Shows Increase in NAD+ Levels, Additional Research Highlights Downfalls of Nicotinamide Mononucleotide (NMN)"
2020-05-01,"ChromaDex to Report First Quarter 2020 Financial Results on Monday, May 11, 2020"
2020-04-28,"Cellular Health Market Leader Tru Niagen® to Launch in U.K. Online and in Retail Stores Exclusively with Superdrug, Expanding Global Retail Partnership Between ChromaDex and A.S. Watson Group"
2020-04-27,We're Hopeful That ChromaDex (NASDAQ:CDXC) Will Use Its Cash Wisely
2020-04-24,ChromaDex (CDXC) Jumps: Stock Rises 7.7%
2020-04-23,"ChromaDex and Watsons Launch New Tru Niagen® Beauty Cellular Nutrient in Hong Kong, Broadening Global Retail Partnership"
2020-04-20,ChromaDex Commits to COVID-19 Research Following Promising Initial Preclinical Findings Showing Viral Infections Deplete NAD and SARS-CoV-2-Infected Cells Activate NAD Defense Pathway That Utilizes Nicotinamide Riboside (NR)
2020-04-14,"Elysium Health, Inc. Loses Appeal of Patent Challenge Decision, Upholding Validity of ChromaDex Intellectual Property"
2020-03-23,Cellular Health Market Leader Tru Niagen® Launches Online in Australia
2020-03-16,Edited Transcript of CDXC earnings conference call or presentation 10-Mar-20 8:30pm GMT
2020-03-13,US$7.38: That's What Analysts Think ChromaDex Corporation Is Worth After Its Latest Results
2020-03-12,ChromaDex Corrects Statements Made by an Unaffiliated Third Party Regarding its Product and COVID-19
2020-03-10,"ChromaDex (CDXC) Reports Q4 Loss, Tops Revenue Estimates"
2020-03-10,CHROMADEX CORPORATION REPORTS 2019 FINANCIAL RESULTS
2020-03-10,Chromadex Corp. to Host Earnings Call
2020-03-03,ChromaDex (CDXC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
2020-02-27,New Niagen® Nicotinamide Riboside (NR) Study Deepens Understanding of NAD Decline and Hearing Loss in Animal Model
2020-02-25,"ChromaDex to Report Fourth Quarter 2019 Financial Results on Tuesday, March 10, 2020"
2020-02-12,"ChromaDex Partners with Personalized Nutrition Company, Persona Nutrition, Expanding Global Partnership with Nestlé Health Science"
2020-02-03,ChromaDex Launches New Line of High Purity Cannabinoid (CBD) Reference Standards Available for Research and Analytical Testing Worldwide
2020-01-15,ChromaDex Achieves New Regulatory Milestones in the European Union & Australia
2020-01-06,First-of-its-Kind Clinical Study Initiated to Investigate Potential Benefits of Nicotinamide Riboside Combined with Exercise in Older Adults with Hypertension
2019-12-30,Should ChromaDex (NASDAQ:CDXC) Be Disappointed With Their 69% Profit?
2019-12-23,Hedge Funds Have Never Been More Bullish On ChromaDex Corporation (CDXC)
2019-12-16,ChromaDex Wins Nutritional Outlooks 2019 Best of Industry Ingredient Supplier Award for Niagen®
2019-12-11,"ChromaDex Launches Tru Niagen® Pro 500, the Largest Serving of Patented Nicotinamide Riboside Available Worldwide"
2019-12-05,ChromaDex and Matakana Announce Expanded Retail Partnership in Australia & New Zealand
2019-12-02,ChromaDex Receives Approval for Nicotinamide Riboside Chloride as an Ingredient for Complementary Medicines from the Australian Therapeutic Goods Administration (TGA)
2019-12-01,Edited Transcript of CDXC earnings conference call or presentation 12-Nov-19 9:30pm GMT
2019-11-20,European Commission Votes in Favor on Nicotinamide Riboside Chloride as a Novel Food
2019-11-12,"ChromaDex (CDXC) Reports Q3 Loss, Tops Revenue Estimates"
2019-11-12,ChromaDex Corporation Reports Third Quarter 2019 Financial Results
2019-11-11,Does Market Volatility Impact ChromaDex Corporation's (NASDAQ:CDXC) Share Price?
2019-11-05,Will ChromaDex (CDXC) Report Negative Earnings Next Week? What You Should Know
2019-11-04,"ChromaDex to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019"
2019-10-31,Tru Niagen® Wins Most Favourite Brand Award Among Watsons Hong Kong Loyalty Members
2019-10-30,ChromaDex (CDXC) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
2019-10-17,New Study Demonstrates a Unique Role of Nicotinamide Riboside Over Other NAD Precursors
2019-10-11,ChromaDex Statement Regarding the October 9th Order in the Central District of California Litigation
2019-10-07,Humanitarian Grant Awarded for Preclinical Study on the Impact of NAD Precursor Vitamins on Milk Bioactive Production and Brain Development in Rodents
2019-09-26,ChromaDex to Present at the 5th Annual B. Riley FBR Consumer and Media Conference
2019-09-10,Industry Leaders Aubrey De Grey And Frank Jaksch Join Yuva Biosciences Advisory Board
2019-08-15,Edited Transcript of CDXC earnings conference call or presentation 7-Aug-19 8:30pm GMT
2019-08-14,ChromaDex Announces $7 Million Private Placement of Common Stock
2019-08-08,ChromaDex Corporation (CDXC) Q2 2019 Earnings Call Transcript
2019-08-07,"ChromaDex (CDXC) Reports Q2 Loss, Tops Revenue Estimates"
2019-08-07,ChromaDex Receives Positive Opinion on Nicotinamide Riboside as a Novel Food from the World-Leading European Food Safety Authority (EFSA)
2019-08-07,ChromaDex Corporation Reports Second Quarter 2019 Financial Results
2019-08-06,ChromaDex Adds Top Talent to its Leadership Team
2019-08-01,ChromaDex (CDXC) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
2019-07-31,"ChromaDex to Report Second Quarter 2019 Financial Results on Wednesday, August 7, 2019"
2019-07-24,TRU NIAGEN® Expands Canadian Retail Footprint with Distribution at Whole Foods Ontario Locations
2019-07-23,"ChromaDex Appoints Scripps Research Professor of Molecular Medicine, Brunie H. Felding, PhD, to the Scientific Advisory Board"
2019-07-08,ChromaDex Shares Nicotinamide Riboside Study Results
